Keryx Biopharmaceuticals, Inc. Debt to Equity Ratio 2010-2018 | KERX
Current and historical debt to equity ratio values for Keryx Biopharmaceuticals, Inc. (KERX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Keryx Biopharmaceuticals, Inc. debt/equity for the three months ending September 30, 2018 was .
Debt/Equity Ratio Historical Data |
Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
2018-09-30 |
$0.21B |
$-0.05B |
-3.80 |
2018-06-30 |
$0.19B |
$-0.04B |
-4.54 |
2018-03-31 |
$0.17B |
$-0.03B |
-5.43 |
2017-12-31 |
$0.17B |
$-0.01B |
-12.27 |
2017-09-30 |
$0.17B |
$0.01B |
18.40 |
2017-06-30 |
$0.16B |
$0.03B |
6.18 |
2017-03-31 |
$0.15B |
$-0.02B |
-6.67 |
2016-12-31 |
$0.15B |
$-0.01B |
-18.05 |
2016-09-30 |
$0.15B |
$0.02B |
6.67 |
2016-06-30 |
$0.15B |
$0.06B |
2.54 |
2016-03-31 |
$0.18B |
$0.05B |
3.65 |
2015-12-31 |
$0.17B |
$0.09B |
1.98 |
2015-09-30 |
$0.03B |
$0.12B |
0.28 |
2015-06-30 |
$0.03B |
$0.15B |
0.20 |
2015-03-31 |
$0.04B |
$0.17B |
0.22 |
2014-12-31 |
$0.03B |
$0.07B |
0.41 |
2014-09-30 |
$0.03B |
$0.10B |
0.29 |
2014-06-30 |
$0.02B |
$0.12B |
0.15 |
2014-03-31 |
$0.02B |
$0.14B |
0.11 |
2013-12-31 |
$0.02B |
$0.05B |
0.34 |
2013-09-30 |
$0.02B |
$0.06B |
0.28 |
2013-06-30 |
$0.01B |
$0.07B |
0.16 |
2013-03-31 |
$0.01B |
$0.08B |
0.10 |
2012-12-31 |
$0.01B |
$0.01B |
0.77 |
2012-09-30 |
$0.01B |
$0.02B |
0.46 |
2012-06-30 |
$0.01B |
$0.02B |
0.43 |
2012-03-31 |
$0.01B |
$0.02B |
0.55 |
2011-12-31 |
$0.01B |
$0.03B |
0.40 |
2011-09-30 |
$0.01B |
$0.04B |
0.32 |
2011-06-30 |
$0.01B |
$0.05B |
0.20 |
2011-03-31 |
$0.01B |
$0.02B |
0.53 |
2010-12-31 |
$0.01B |
$0.02B |
0.38 |
2010-09-30 |
$0.01B |
$0.03B |
0.38 |
2010-06-30 |
$0.01B |
$0.03B |
0.33 |
2010-03-31 |
$0.01B |
$0.03B |
0.29 |
2009-12-31 |
$0.01B |
$0.03B |
0.27 |
2009-09-30 |
$0.01B |
$0.04B |
0.30 |
2009-06-30 |
$0.01B |
$0.02B |
0.61 |
2009-03-31 |
$0.03B |
$0.00B |
-57.63 |